Incyte reports Q3 results, updates 2015 guidance

• Incyte Corp. (NASDAQ:INCY +4.4%) Q3 results: Revenues: $187.6M (-5.3%); COGS: $8M (+999%); R&D Expense: $132.1M (+49.3%); SG&A: $47.6M (+20.8%); Operating Loss: ($0.1M); Net Loss: ($39.6M) (-166.8%); Loss Per Share: ($0.22) (-166.7%); Quick Assets: $635M (+5.8%).
• 2015 Guidance: Jakafi net product revenues: $580M - 590M from $560M - 575M; R&D: $475M - 500M (unch); SG&A: $200M - 210M from $195M - 210M.